ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

BTAI BioXcel Therapeutics Inc

2.57
0.01 (0.39%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
BioXcel Therapeutics Inc BTAI NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.39% 2.57 09:00:00
始値 安値 高値 終値 前日終値
2.60 2.56 2.6701 2.57 2.56
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2520:00GLOBEBioXcel Therapeutics to Report First Quarter 2024 Financial..
2024/4/2423:30GLOBEBioXcel Therapeutics Announces Late-Breaking Abstract on..
2024/4/2220:00GLOBEBioXcel Therapeutics Announces Plan for Evaluating BXCL501..
2024/4/1020:00GLOBEBioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal..
2024/3/2520:00GLOBEBioXcel Therapeutics Announces $25 Million Registered Direct..
2024/3/1520:00GLOBEBioXcel Therapeutics Announces European Patent Office’s..
2024/3/1220:00GLOBEBioXcel Therapeutics Reports Financial Results for the..
2024/3/0121:00GLOBEBioXcel Therapeutics to Report Fourth Quarter and Full Year..
2024/2/1421:00EDGAR2Form 8-K - Current report
2024/2/1323:00GLOBEBioXcel Therapeutics Announces Termination of Proposed..
2024/2/1302:45EDGAR2Form 8-K - Current report
2024/2/1221:14GLOBEBioXcel Therapeutics Receives FDA Fast Track Designation for..
2024/2/0907:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0906:53EDGAR2Form 8-K - Current report
2024/2/0906:01GLOBEBioXcel Therapeutics Announces Proposed Public Offering
2024/2/0821:08EDGAR2Form 8-K - Current report
2024/2/0621:00GLOBEBioXcel Therapeutics Announces Completion of Patient..
2024/2/0521:00GLOBEBioXcel Therapeutics Announces USPTO’s Allowance of Patent..
2024/1/2314:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/1306:16EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/12/1906:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1906:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1906:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1821:22EDGAR2Form 8-K - Current report
2023/12/1221:00EDGAR2Form 8-K - Current report
2023/12/1221:00GLOBEBioXcel Therapeutics Hosting Virtual Neuroscience R&D Day..
2023/12/1121:00GLOBEBioXcel Therapeutics Strengthens Clinical Development..
2023/12/0621:00EDGAR2Form 8-K - Current report
2023/11/3021:00GLOBEBioXcel Therapeutics to Host Virtual Neuroscience R&D Day on..
2023/11/1401:59EDGAR2Form RW WD - Withdrawal of Registration Withdrawal Request
2023/11/1400:23EDGAR2Form RW - Registration Withdrawal Request
2023/11/0821:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
2023/11/0621:00GLOBEBioXcel Therapeutics Announces Update on NIDA-funded Trial..
2023/11/0219:01EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/10/3120:00GLOBEBioXcel Therapeutics to Report Third Quarter 2023 Financial..
2023/10/3020:00GLOBEBioXcel Therapeutics Receives Permanent J-Code for IGALMI™..
2023/10/2523:30APSStrong Open For Biotech Shares Following Phase 3 Comments
2023/10/2520:00GLOBEBioXcel Therapeutics Announces Positive Findings from..
2023/10/2005:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/10/1020:06EDGAR2Form 8-K - Current report
2023/10/1020:00GLOBEBioXcel Therapeutics Reports Positive Overall Survival..
2023/10/0420:05EDGAR2Form 8-K - Current report
2023/10/0420:00GLOBEBioXcel Therapeutics Provides Update on Recent Developments..
2023/9/2606:07EDGAR2Form 8-K - Current report
2023/9/2100:21EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2100:15EDGAR2Form 144 - Report of proposed sale of securities
2023/9/1921:00EDGAR2Form 8-K - Current report
2023/9/1905:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1905:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1905:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock